GlucaGen is a Intramuscular; Intravenous; Subcutaneous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Glucagon Hydrochloride.
Product ID | 0597-0053_0ff3a5b5-37eb-4bc4-a423-a218a0dbd8a2 |
NDC | 0597-0053 |
Product Type | Human Prescription Drug |
Proprietary Name | GlucaGen |
Generic Name | Glucagon Hydrochloride |
Dosage Form | Injection, Powder, For Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 2005-06-22 |
Marketing Category | NDA / NDA |
Application Number | NDA020918 |
Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
Substance Name | GLUCAGON HYDROCHLORIDE |
Active Ingredient Strength | 1 mg/mL |
Pharm Classes | Antihypoglycemic Agent [EPC],Gastrointestinal Motility Inhibitor [EPC],Increased Gluconeogenesis [PE],Increased Glycogenolysis [PE],Decreased GI Smooth Muscle Tone [PE],Decreased GI Motility [PE],Decreased Glycolysis [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2005-06-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020918 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-06-22 |
Ingredient | Strength |
---|---|
GLUCAGON HYDROCHLORIDE | 1 mg/mL |
SPL SET ID: | ff16e4b1-3668-4cb4-91a4-77ee509cd6f6 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0597-0053 | GlucaGen | glucagon hydrochloride |
0597-0260 | GlucaGen | glucagon hydrochloride |
0169-7065 | GlucaGen HypoKit | glucagon hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
GLUCAGEN 77009824 3254580 Live/Registered |
Novo Nordisk A/S 2006-09-28 |
GLUCAGEN 74145009 1841542 Dead/Cancelled |
NOVO NORDISK A/S 1991-03-06 |